These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6354460)

  • 1. [Metabolic effect of glucagon in obese individuals. I. Effect on blood glucose and blood insulin].
    Beno I; Chorváthová V; Ozdin L; Ovecka M
    Cas Lek Cesk; 1983 Sep; 122(35):1070-4. PubMed ID: 6354460
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic effect of glucagon in obese individuals. II. Effect on the levels of nonesterified fatty acids and beta-hydroxybutyric acid in the blood].
    Beno I; Chorváthová V; Jurcovicová M
    Cas Lek Cesk; 1983 Nov; 122(44):1360-3. PubMed ID: 6640603
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of fasting and refeeding on glucose, insulin and glucagon concentrations in obese teenagers.
    Villalpando-Hernández S; Pang SJ; Hopwood N; Becker D; Drash A
    Arch Invest Med (Mex); 1982; 13(4):255-60. PubMed ID: 6758722
    [No Abstract]   [Full Text] [Related]  

  • 4. [Critical considerations regarding the obesity-hyperinsulinism concept].
    Melani F
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():332-40. PubMed ID: 4907222
    [No Abstract]   [Full Text] [Related]  

  • 5. Zinc status in plasma of obese individuals during glucose administration.
    Chen MD; Lin PY; Sheu WH
    Biol Trace Elem Res; 1997; 60(1-2):123-9. PubMed ID: 9404681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of fasting and post oral glucose serum insulin levels in hypertensive and obese subjects.
    Kothari K; Mathur A; Yadav S
    J Assoc Physicians India; 1998 Jun; 46(6):514-7. PubMed ID: 11273248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the metabolic action of glucagon in subjects undergoing anti-insulin therapy].
    Marugo M; Mortara R; Baiardi M; Giusti M; Motta A; Grimaldi GP
    Clin Ter; 1981 Mar; 96(6):579-92. PubMed ID: 7026132
    [No Abstract]   [Full Text] [Related]  

  • 8. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nacton-induced cholinergic block and its effect on insulin secretion in obese patients].
    Hainer V; Zák A; Bakos K; Wernischová V; Bĕlikovová H
    Cas Lek Cesk; 1982 Jul; 121(27):844-7. PubMed ID: 6749290
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of insulin and glucagon on the anomeric composition of D-glucose in blood (author's transl)].
    Madreiter H; Jarosch E; Richter H
    Padiatr Padol; 1975; 10(3):230-6. PubMed ID: 1196660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of verapamil on the metabolic action of glucagon.
    Ferlito S; Del Campo F; Damante G; Di Vincenzo S; Costa A; Branca S
    Horm Metab Res; 1982 Nov; 14(11):611. PubMed ID: 6759354
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of insulin and growth hormone levels in oral and intravenous glucose overload in normal and obese women].
    Claro López A; Diáz Méndez MN; Licea Puig M
    Rev Clin Esp; 1984 Apr; 173(2):91-3. PubMed ID: 6377415
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.
    Prigeon RL; Quddusi S; Paty B; D'Alessio DA
    Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E701-7. PubMed ID: 12773303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin levels in plasma during a 3-hour blood glucose profile in obese children monitored by the Biostator].
    Stejskalová S; Kudlík D; Lavický P; Brázdová L
    Cesk Pediatr; 1989 Oct; 44(10):619-21. PubMed ID: 2695258
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunoreactive plasmatic insulin (IRI) in hyperthyreosis and myxedema. Effects of glucose and glucagon in intravenous injection].
    Andreani D; Menzinger G; Fallucca F; Tamburrano G; Aliberti G
    Folia Endocrinol; 1968 Feb; 21(1):18-30. PubMed ID: 5754871
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood insulin, glucagon and glucose levels in latent diabetes mellitus determined during glucose tolerance test (effect of phenformin)].
    Tikhonova NE
    Ter Arkh; 1982; 54(10):12-6. PubMed ID: 6758166
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma insulin changes in obesity with or without abnormal glucose tolerance].
    García Pascual IJ; González Ruiz JM
    An Med Interna; 1993 Oct; 10(10):473-8. PubMed ID: 8136423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between blood glucose, insulin and hypertension in 60 obese children].
    Guo X; Li J; Ma G
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):25-7. PubMed ID: 10322748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.